RARE Partnering and Investor Forum

2.9 from 12 votes
Date: 14 September, 2017
Location: Irvine, CA, USA

The first-Ever Rare Disease partnering event where Science Innovators and Investors Converge

EBD Group’s 1:1 Partnering Platform
Compelling Agenda with Industry Experts * Company Presentations
‘Shark Tank’-Style Pitch Competition Featuring Promising Early Stage Companies
Vying for Valuable Goods and Services


Participating Partners and Investors (to date):

John Crowley, Chairman and CEO, Amicus Therapeutics Brad Margus, Founder & CEO, Cerevance
Bharatt Chowrira, President & Chief of Business & Strategy, PureTech Health Camille Samuels, Managing Partner, Venrock
Neil Kumar, CEO, BridgeBio Alison Silva, CEO & President, Critical Outcome Technologies Inc., The Orphan Group
Michael Pistone, Strategic Marketing & Business Development, Cincinnati Children’s Hospital Matthew Howes, EVP, Strategy & Growth, Palio
Jeremy Springhorn, Flagship Pioneering Ashish Sagrolikare, Office of Commercial Transformation, GSK
Art Pappas, Managing Partner, Pappas Capital Vern Norviel, Partner, Wilson Sonsini Goodrich & Rosati
Kush Parmar, MD, Ph.D., Managing Partner,
5AM Ventures
Michael Broxson, VP, Manager Business Development, Takeda Pharmaceuticals
2.9 from 12 votes